Radiology, Liver cancer Center
Clinical Assistant Professor, Department of Radiology, Liver cancer Center, Sungkyunkwan University School of Medicine, Samsung Medical Center

Speciality Interests

Abdominal imaging and interventional oncology

Schedule

schedule of week
05 FRI
02
MON
05
TUE
06
WEN
07
THU
08
AM
PM

Medical School

Sungkyunkwan University College of Medicine

Specialty Training

Specialty Training
Fellowship   Department of Radiology, Sansung Medical Center
Residency   Department of Radiology, Sansung Medical Center
Internship   Sansung Medical Center

Participation in Academic Societies
and Research

  • Member, Korean Society of Radiology
    Member, Korean Society of Ultrasound in Medicine
    Member, Korean Society of Image-guided tumor ablation
    Member, Korean Society of Abdominal radiology
    Member, Korean Society of Interventional radiology

Thesis

  • ACTA RADIOL 2024 10.1177/02841851241295392 Percutaneous radiofrequency ablation of hepatocellular carcinomas abutting the right posterior diaphragm: factors associated with tumor recurrence and overall survival Lee, JS; Ahn, SH; Lee, MW; Han, SC; Min, JH; Cha, DI; Song, KD; Kang, TW; Rhim, H
    View PubMed
  • J HEPATOL 2024 10.1016/j.jhep.2024.03.048 Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC Kim, DH; Yoon, JH; Choi, MH; Lee, CH; Kang, TW; Kim, HA; Ku, YM; Lee, JM; Kim, SH; Kim, KA; Lee, SL; Choi, JI
    View PubMed
  • EUR J RADIOL 2024 10.1016/j.ejrad.2024.111560 Gastrointestinal tract perforation after radiofrequency ablation for hepatic tumor: Incidence and risk factors Gu, K; Kang, TW; Han, S; Cha, DI; Song, KD; Lee, MW; Rhim, H; Park, GE
    View PubMed
  • PLOS ONE 2024 10.1371/journal.pone.0304352 Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma Ban, JY; Kang, TW; Jeong, WK; Lee, MW; Park, B; Song, KD
    View PubMed
  • CLIN IMAG 2024 10.1016/j.clinimag.2024.110097 Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics Song, BG; Kang, TW; Sinn, DH; Kim, YY; Min, JH; Hwang, JA; Shin, J
    View PubMed
  • EUR RADIOL 2024 10.1007/s00330-023-09936-y Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria Cha, DI; Kang, TW; Jeong, WK; Kim, JM; Choi, GS; Joh, JW; Yi, NJ; Ahn, SH
    View PubMed
  • EUR RADIOL 2024 10.1007/s00330-023-09998-y LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation Min, JH; Lee, MW; Rhim, H; Han, S; Song, KD; Kang, TW; Jeong, WK; Cha, DI; Kim, JM; Choi, GS; Kim, K
    View PubMed
  • KOREAN J RADIOL 2023 10.3348/kjr.2023.0022 Treatment Outcomes of Percutaneous Radiofrequency Ablation for Hepatocellular Carcinomas: Effects of the Electrode Type and Placement Method Park, J; Lee, MW; Ahn, SH; Han, S; Min, JH; Cha, DI; Song, KD; Kang, TW; Rhim, H
    View PubMed
  • EUR RADIOL 2023 10.1007/s00330-023-09919-z Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion Taouli, B; Ba-Ssalamah, A; Chapiro, J; Chhatwal, J; Fowler, K; Kang, TW; Knobloch, G; Koh, DM; Kudo, M; Lee, JM; Murakami, T; Pinato, DJ; Ringe, KI; Song, B; Tabrizian, P; Wang, J; Yoon, JH; Zeng, MS; Zhou, J; Vilgrain, V
    View PubMed
  • EUR RADIOL 2023 10.1007/s00330-023-09928-y Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management Taouli, B; Ba-Ssalamah, A; Chapiro, J; Chhatwal, J; Fowler, K; Kang, TW; Knobloch, G; Koh, DM; Kudo, M; Lee, JM; Murakami, T; Pinato, DJ; Ringe, KI; Song, B; Tabrizian, P; Wang, J; Yoon, JH; Zeng, MS; Zhou, J; Vilgrain, V
    View PubMed
  • BRIT J RADIOL 2023 10.1259/bjr.20211037 Rescue therapy for local tumor progression after radiofrequency ablation of small hepatocellular carcinoma: a comparison between repeated ablation and transcatheter arterial chemoembolization Cha, DI; Lee, MW; Ahn, SH; Song, KD; Kang, TW; Sinn, DH; Rhim, H
    View PubMed
  • CANCERS 2023 10.3390/cancers15030687 Risk Group Stratification for Recurrence-Free Survival and Early Tumor Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma Cha, DI; Ahn, SH; Lee, MW; Jeong, WK; Song, KD; Kang, TW; Rhim, H
    View PubMed
  • AM J ROENTGENOL 2022 10.2214/AJR.22.27739 Utility of Diffusion-Weighted MRI for Detection of Locally Recurrent Pancreatic Cancer After Surgical Resection Shin, N; Kang, TW; Min, JH; Hwang, JA; Kim, YK; Kim, YY; Han, IW; Kim, K
    View PubMed
  • ULTRASONOGRAPHY 2022 10.14366/usg.21256 Percutaneous radiofrequency ablation of solitary hepatic metastases from colorectal cancer: risk factors of local tumor progression-free survival and overall survival Lee, HJ; Lee, MW; Ahn, SH; Cha, DI; Ko, SE; Kang, TW; Song, KD; Rhim, H
    View PubMed
  • KOREAN J RADIOL 2022 10.3348/kjr.2021.0786 Laparoscopic Hepatic Resection Versus Laparoscopic Radiofrequency Ablation for Subcapsular Hepatocellular Ko, SE; Lee, MW; Ahn, S; Rhim, H; Kang, TW; Song, KD; Kim, JM; Choi, GS; Cha, DI; Min, JH; Sinn, DH; Choi, MS; Lim, HK
    View PubMed
  • ULTRASONOGRAPHY 2022 10.14366/usg.22041 Percutaneous radiofrequency ablation of hepatocellular carcinoma in a recent cohort at a tertiary cancer center: incidence and factors associated with major complications and unexpected hospitalization events Jo, MG; Lee, MW; Ahn, S; Kang, TW; Song, KD; Cha, DI; Min, JH; Rhim, H
    View PubMed
  • EUR J RADIOL 2022 10.1016/j.ejrad.2022.110328 Association between intensity of imaging surveillance and clinical outcomes in patients with hepatocellular carcinoma Hwang, JA; Kang, TW; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Kim, K
    View PubMed
  • ULTRASONOGRAPHY 2022 10.14366/usg.21241 Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma Kwak, MH; Lee, MW; Ko, SE; Rhim, H; Kang, TW; Song, KD; Kim, JM; Choi, GS
    View PubMed
  • KOREAN J RADIOL 2022 10.3348/kjr.2021.0134 Direction of Tissue Contraction after Microwave Ablation: A Comparative Experimental Study in Ex Vivo Bovine Liver Lee, J; Rhim, H; Lee, MW; Kang, TW; Song, KD; Lee, JK
    View PubMed
  • GENOME MED 2022 10.1186/s13073-021-00995-8 Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial Hong, JY; Cho, HJ; Sa, JK; Liu, XQ; Ha, SY; Lee, T; Kim, H; Kang, W; Sinn, DH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Park, HC; Kang, TW; Rhim, H; Lee, SJ; Cristescu, R; Lee, J; Paik, YH; Lim, HY
    View PubMed
  • ULTRASONOGRAPHY 2022 10.14366/usg.21050 Percutaneous radiofrequency ablation for hepatic metastasis of colorectal cancer: assessment of tumor visibility and the feasibility of the procedure with planning ultrasonography Bae, JW; Lee, MW; Kang, TW; Song, KD; Cha, DI; Min, JH; Rhim, H
    View PubMed
  • BRIT J RADIOL 2021 10.1259/bjr.20210353 Hemostasis using re- radiofrequency ablation for hepatic tract bleeding after ultrasound- guided percutaneous radiofrequency ablation of hepatic tumors Song, KD; Lee, MW; Rhim, H; Kang, TW
    View PubMed
  • ULTRASONOGRAPHY 2021 10.14366/usg.20179 Deep learning-based automated quantification of the hepatorenal index for evaluation of fatty liver by ultrasonography Cha, DI; Kang, TW; Min, JH; Joo, I; Sinn, DH; Ha, SY; Kim, K; Lee, G; Yi, J
    View PubMed
  • ADV SCI 2021 10.1002/advs.202100725 Real-Time Internal Steam Pop Detection during Radiofrequency Ablation with a Radiofrequency Ablation Needle Integrated with a Temperature and Pressure Sensor: Preclinical and Clinical Pilot Tests Park, J; Cha, DI; Jeong, Y; Park, H; Lee, J; Kang, TW; Lim, HK; Park, I
    View PubMed
  • EUR RADIOL 2021 10.1007/s00330-021-08124-0 A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions Min, JH; Kim, JM; Kim, YK; Kim, H; Choi, GS; Kang, TW; Cha, D; Hwang, JA; Ko, SE; Ahn, S
    View PubMed
  • LIVER INT 2021 10.1111/liv.15012 EASL versus LI-RADS: Intra-individual comparison of MRI with extracellular contrast and gadoxetic acid for diagnosis of small HCC Min, JH; Kim, JM; Kim, YK; Kim, H; Cha, DI; Kang, TW; Choi, GS; Choi, SY; Ahn, S
    View PubMed
  • ANN SURG 2021 Response to the Comment on Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation Lee, S; Kang, TW
    View PubMed
  • EUR RADIOL 2021 10.1007/s00330-021-07897-8

    Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT

    Hwang1, JA; Min, JH; Kang, TW; Jeong, WK; Kim, YK; Ko, SE; Choi, SY

    ULTRASONOGRAPHY 2021 10.14366/usg.20059

    The semi-erect position for better visualization of subphrenic hepatocellular carcinoma during ultrasonography examinations

    Ko1, SE; Lee, MW; Lim, HK; Min, JH; Cha, DI; Kang, TW; Song, KD; Kim, MJ; Rhim, H

    ANN SURG 2021 10.1097/SLA.0000000000003268

    Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation

    Lee1, S; Kang, TW; Song, KD; Lee, MW; Rhim, H; Lim, HK; Kim, SY; Sinn, DH; Kim, JM; Kim, K; Ha, SY

    EUR RADIOL 2021 10.1007/s00330-021-07769-1

    Rim-arterial enhancing primary hepatic tumors with other targetoid appearance show early recurrence after radiofrequency ablation

    Cha1, DI; Lee, MW; Jeong, WK; Ahn, SH; Kang, TW; Song, KD; Min, JH; Rhim, H; Lim, HK

    SURG ENDOSC 2021 10.1007/s00464-021-08310-7

    Laparoscopic radiofrequency ablation of subcapsular hepatocellular carcinomas: risk factors related to a technical failure

    Ko1, SE; Lee, MW; Min, JH; Ahn, SH; Rhim, H; Kang, TW; Song, KD; Kim, JM; Choi, GS; Cha, DI; Lim, HK

    EUR J RADIOL 2021 10.1016/j.ejrad.2020.109474

    Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor

    Kim1, YY; Kang, TW; Cha, DI; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Won, H; Kim, S

    RADIOLOGY 2021 10.1148/radiol.2020200885

    Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia

    Kang1, TW; Jeong, WK; Kim, YY; Min, JH; Kim, YK; Kim, SH; Sinn, DH; Kim, K

    EUR RADIOL 2020 10.1007/s00330-020-07438-9

    Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis diagnostic performance of CT and MRI

    Min1, JH; Kang, TW; Kim, YY; Cha, DI; Kim, YK; Kim, SH; Sinn, DH; Ha, SY; Kim, K

    INT J HYPERTHER 2020 10.1080/02656736.2020.1849824

    Comparison of procedure-related complications between percutaneous cryoablation and radiofrequency ablation for treating periductal hepatocellular carcinoma

    Ko1, SE; Lee, MW; Rhim, H; Kang, TW; Song, KD; Cha, DI; Lim, HK

    ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238

    Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria

    Oh1, JH; Sinn, DH; Choi, GS; Kim, JM; Joh, JW; Kang, TW; Hyun, D; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS

    KOREAN J RADIOL 2020 10.3348/kjr.2019.0910

    Effect of Perfluorobutane Microbubbles on Radiofrequency Ablation for Hepatocellular Carcinoma Suppression of Steam Popping and Its Clinical Implication

    Jeong1, DY; Kang, TW; Min, JH; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Han, H

    RADIOLOGY 2020 10.1148/radiol.2020192275

    Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI A Multicenter Study

    Joo1, I; Kim, SY; Kang, TW; Kim, YK; Park, BJ; Lee, YJ; Choi, JI; Lee, CH; Park, HS; Lee, K; Kim, H; Yu, E; Kang, HJ; Ha, SY; Kim, JY; Ahn, S; Jung, ES; Kim, BH; Han, HS; Lee, JM

    CLIN GASTROENTEROL H 2020 10.1016/j.cgh.2019.12.010

    Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography

    Min1, JH; Kim, JM; Kim, YK; Cha, DI; Kang, TW; Kim, H; Choi, GS; Choi, SY; Ahn, S

    APPL SCI-BASEL 2020 10.3390/app10134607

    Treatment Selection for Early to Intermediate Hepatocellular Carcinoma

    Nouso1, K; Ohki, T; Yamashita, T; Takaki, H; Liu, CA; Kang, TW; Lee, DH; Lee, SJ; Kulkarni, S; Shree, D; Tanaka, M

    RADIOLOGY 2020 10.1148/radiol.2020190639

    Use of Gadoxetic Acid enhanced Liver MRI and Morality in More than 30000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis

    Kang1, TW; Kong, SY; Kang, D; Kang, MW; Kim, YK; Kim, SH; Sinn, DH; Kim, YA; Choi, KS; Lee, ES; Cho, J; Guallar, E; Back, JH; Woo, SM

    EUR RADIOL 2020 10.1007/s00330-019-06575-0

    Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival

    Lee1, MW; Kang, D; Lim, HK; Cho, J; Sinn, DH; Kang, TW; Song, KD; Rhim, H; Cha, DI; Lu, DSK

    EUR RADIOL 2020 10.1007/s00330-020-06753-5

    Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS

    Cha1, DI; Choi, GS; Kim, YK; Kim, JM; Kang, TW; Song, KD; Ahn, SH

    CARDIOVASC INTER RAD 2020 10.1007/s00270-019-02394-4

    RF Ablation Versus Cryoablation for Small Perivascular Hepatocellular Carcinoma: Propensity Score Analyses of Mid-Term Outcomes

    Cha1, SY; Kang, TW; Min, JH; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Park, MS

    EUR RADIOL 2020 10.1007/s00330-019-06407-1

    Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network

    Lee1, JH; Joo, I; Kang, TW; Paik, YH; Sinn, DH; Ha, SY; Kim, K; Choi, C; Lee, GW; Yi, JH; Bang, WC

    BRIT J RADIOL 2020 10.1259/bjr.20190719

    Small masses (<= 3 cm) diagnosed as hepatocellular carcinoma on pre-treatment imaging: comparison of therapeutic outcomes between hepatic resection and radiofrequency ablation

    Cha1, DI; Song, KD; Kang, TW; Lee, MW; Rhim, H

    EUR RADIOL 2019 10.1007/s00330-018-5993-y

    Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival

    Lee1, DH; Lee, JM; Kim, PN; Jang, YJ; Kang, TW; Rhim, H; Seo, JW; Lee, YJ

    Abdom Radiol (NY) 2019 10.1007/s00261-019-01968-7

    Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI

    Yim1, JH; Kim, YK; Min, JH; Lee, J; Kang, TW; Lee, SJ

    EUR RADIOL 2019 10.1007/s00330-018-5868-2

    Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure

    Cha1, DI; Kang, TW; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Kim, K

    CLIN RADIOL 2019 10.1016/j.crad.2019.01.019

    Questionable correlation of the apparent diffusion coefficient with the histological grade and microvascular invasion in small hepatocellular carcinoma

    Kim1, JG; Jang, KM; Min, GS; Kang, TW; Cha, DI; Ahn, SH

    ACTA RADIOL 2019 10.1177/0284185119842830

    Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension

    Kim1, R; Jeong, WK; Kang, TW; Song, KD; Lee, MW; Ahn, SH; Rhim, H

    Abdom Radiol (NY) 2019 10.1007/s00261-018-1814-7

    Differences in early imaging features and pattern of progression on CT between intrahepatic biliary metastasis of colorectal origin and intrahepatic non-mass-forming cholangiocarcinoma in patients with extrabiliary malignancy

    Min1, JH; Jang, KM; Cha, DI; Kang, TW; Kim, SH; Choi, SY; Min, K

    WORLD J GASTROINTEST ONCOL 2019 10.4251/wjgo.v11.i3.227

    Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm

    Song1, KD; Lim, HK; Rhim, H; Lee, MW; Kang, TW; Paik, YH; Kim, JM; Joh, JW

    RADIOLOGY 2019 10.1118/radiol.2018181485

    Intrahepatic Mass-formimg Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis

    Min1, JH; Kim, YK; Choi, SY; Kang, TW; Lee, SJ; Kim, JM; Ahn, S; Cho, H

    EUR RADIOL 2019 10.1007/s00330-018-5617-6

    Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications

    Kim1, R; Kang, TW; Cha, DI; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH

    KOREAN J RADIOL 2019 10.3348/kjr.2018.0339

    Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images

    Kim1, M; Kang, TW; Cha, DI; Jang, KM; Kim, YK; Kim, SH; Sinn, DH; Kim, K

    KOREAN J RADIOL 2019 10.3348/kjr.2018.0320

    Usefulness of Virtual Expiratory CT Images to Compensate for Respiratory Liver Motion in Ultrasound/CT Image Fusion: A Prospective Study in Patients with Focal Hepatic Lesions

    Kang1, TW; Lee, MW; Cha, DI; Park, HJ; Park, JS; Bang, WC; Kim, SW

    EUR RADIOL 2019 10.1007/s00330-018-5602-0

    Apparent diffusion coefficient as a potential marker for tumour differentiation, staging and long-term clinical outcomes in gallbladder cancer

    Min1, JH; Kang, TW; Cha, DI; Kim, SH; Shin, KS; Lee, JE; Jang, KT; Ahn, SH

    EUR RADIOL 2019 10.1007/s00330-018-5657-y

    LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?

    Kim1, SS; Hwang, JA; Shin, HC; Choi, SY; Kang, TW; Jou, SS; Lee, WH; Park, S; Heo, NH

    PLoS One 2019 10.1371/journal.pone.0210730

    Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients

    Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW

    Abdom Radiol (NY) 2018 10.1007/s00261-018-1653-6

    Hepatic neuroendocrine tumors: gadoxetic acid-enhanced magnetic resonance imaging findings with an emphasis on differentiation between primary and secondary tumors

    Cha1, DI; Kang, TW; Jang, KM; Kim, YK; Kim, SH; Ha, SY; Sohn, I

    WORLD J GASTROENTERO 2018 10.3748/wjg.v24.i47.5331

    Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives

    Kang1, TW; Lim, HK; Cha, DI

    HEPATOLOGY 2018 10.1002/hep.30122

    Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System

    Min1, JH; Kim, JM; Kim, YK; Kang, TW; Lee, SJ; Choi, GS; Choi, SY; Ahn, S

    BRIT J RADIOL 2018 10.1259/bjr.20180177

    Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging

    Min1, JH; Kim, YK; Choi, SY; Kang, TW; Jeong, WK; Kim, K; Won, HJ

    J HEPATOL 2018 10.1016/j.jhep.2018.05.032

    Reply to: "Influence of ablation technique on treatment failure for perivascular hepatocellular carcinoma''

    Lee1, S; Kang, TW

    RADIOLOGY 2018 10.1148/radiol.2018172743

    Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes

    Song1, KD; Lee, MW; Rhim, H; Kang, TW; Cha, DI; Sinn, DH; Lim, HK

    EUR RADIOL 2018 10.1007/s00330-018-5307-4

    Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: Multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging

    Min1, JH; Kim, YK; Kang, TW; Jeong, WK; Lee, WJ; Ahn, S; Hwang, NY

    J HEPATOL 2018 10.1016/j.jhep.2018.02.026

    Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes

    Lee1, S; Kang, TW; Cha, DI; Song, KD; Lee, MW; Rhim, H; Lim, HK; Sinn, DH; Kim, JM; Kim, K

    CLIN RADIOL 2018 10.1016/j.crad.2018.02.007

    Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes

    Min1, JH; Kang, TW; Cha, DI; Song, KD; Lee, MW; Rhim, H; Sinn, DH; Kim, JM; Sohn, I

    EUR RADIOL 2018 10.1007/s00330-017-5248-3

    Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival

    Min1, JH; Kang, TW; Kim, YK; Kim, SH; Shin, KS; Lee, JE; Ha, SY; Sohn, I

    EUR RADIOL 2018 10.1007/s00330-017-5196-y

    Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging

    Choi1, SY; Kim, YK; Min, JH; Kang, TW; Jeong, WK; Ahn, S; Won, H

    CAN J GASTROENTEROL HEPATOL 2018 10.1155/2018/7926923

    Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography

    Lee1, MW; Lim, HK; Rhim, H; Cha, DI; Kang, TW; Song, KD; Min, JH; Gwak, GY; Kim, S; Lu, DSK

    J HEPATOL 2018 10.1016/j.jhep.2018.01.024

    Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma

    Kim1, AY; Sinn, DH; Jeong, WK; Kim, YK; Kang, TW; Ha, SY; Park, CK; Choi, GS; Kim, JM; Kwon, CHD; Joh, JW; Kim, MJ; Sohn, I; Jung, SH; Paik, SW; Lee, WJ

    CLIN RADIOL 2018 10.1016/j.crad.2018.01.016

    Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters

    Kim1, M; Kang, TW; Cha, DI; Kim, YK; Kim, SH; Jang, KT; Han, IW; Sohn, I

    BRIT J RADIOL 2018 10.1259/bjr.20170585

    A radiofrequency device for tract ablation after liver biopsy: a single-institution human feasibility study

    Song1, KD; Rhim, H; Lee, MW; Kang, TW; Lim, S

    CLIN RADIOL 2018 10.1016/j.crad.2017.11.001

    Integration of different criteria for borderline resectable pancreatic cancer using classification tree analysis: the use of radiological tumour-vascular interface in correlation with surgical and pathological outcomes

    Hwang1, JA; Jang, KM; Kim, SH; Kang, TW; Song, KD; Cha, DI; Ahn, S

    CLIN RADIOL 2018 10.1016/j.crad.2017.07.020

    Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation

    Kim1, SS; Kang, TW; Kim, M; Lee, MW; Cho, SK; Paik, YH; Kim, MJ

    RADIOLOGY 2018 10.1148/radiol.2017162452

    Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study

    Lee1, DH; Lee, JM; Kang, TW; Rhim, H; Kim, SY; Shin, YM; Seo, JW; Choi, MH; Lee, KB

    CLIN IMAG 2018 10.1016/j.clinimag.2017.08.004

    The qualitative and quantitative image analysis of MR imaging in patients with acute-on-chronic liver failure

    Kang1, TW; Kim, M; Kim, YK; Kim, SH; Sinn, DH; Kim, K

    CARDIOVASC INTER RAD 2017 10.1007/s00270-017-1751-9

    Ultrasound-Guided Radiofrequency Ablation Using a New Electrode with an Electromagnetic Position Sensor for Hepatic Tumors Difficult to Place an Electrode: A Preliminary Clinical Study

    Kang1, TW; Lee, MW; Song, KD; Rhim, H; Lim, HK; Kang, W; Kim, K

    BMC CANCER 2017 10.1186/s12885-017-3819-y

    Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol

    Kim1, HA; Kim, KA; Choi, JI; Lee, JM; Lee, CH; Kang, TW; Ku, YM; Lee, SL; Park, YS; Yoon, JH; Kim, SH; Choi, MH

    ACTA RADIOL 2017 10.1177/0284185117693459

    Automatic image fusion of real-time ultrasound with computed tomography images: a prospective comparison between two auto-registration methods

    Cha1, DI; Lee, MW; Kim, AY; Kang, TW; Oh, YT; Jeong, JY; Chang, JW; Ryu, J; Lee, KJ; Kim, J; Bang, WC; Shin, DK; Choi, SJ; Koh, D; Seo, BK; Kim, K

    DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8

    Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation

    Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW

    ACTA RADIOL 2017 10.1177/0284185116685921

    Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata'' of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness

    Kim1, M; Jang, KM; Kim, SH; Song, KD; Jeong, WK; Kang, TW; Kim, YK; Cha, DI; Kim, K; Yoo, H

    EUR J RADIOL 2017 10.1016/j.ejard.2017.036

    Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma

    Hwang1, JA; Kang, TW; Kim, YK; Kim, SH; Paik, YH; Ha, SY; Kim, S

    EUR RADIOL 2017 10.1007/s00330-017-4804-1

    Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging

    Cha1, DI; Jang, KM; Kim, SH; Kang, TW; Song, KD

    CARDIOVASC INTER RAD 2017 10.1007/s00270-017-1666-5

    Comparison Between CT and MR Images as More Favorable Reference Data Sets for Fusion Imaging-Guided Radiofrequency Ablation or Biopsy of Hepatic Lesions: A Prospective Study with Focus on Patient's Respiration

    Cha1, DI; Lee, MW; Kang, TW; Oh, YT; Jeong, JY; Chang, JW; Ryu, J; Lee, KJ; Kim, J; Bang, WC; Shin, DK; Choi, SJ; Koh, D; Kim, K

    ULTRASOUND MED BIOL 2017 10.1016/j.ultrasmedbio.2017.01.027

    IMAGE FUSION OF REAL-TIME ULTRASONOGRAPHY WITH COMPUTED TOMOGRAPHY: FACTORS AFFECTING THE REGISTRATION ERROR AND MOTION OF FOCAL HEPATIC LESIONS

    Lee1, MW; Park, HJ; Kang, TW; Ryu, J; Bang, WC; Lee, B; Lee, ES; Choi, BI

    EUR RADIOL 2017 10.1007/s00330-016-4662-2

    Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants

    Kim1, M; Kang, TW; Jeong, WK; Kim, YK; Kim, SH; Kim, JM; Sinn, DH; Kim, MJ; Jung, SH

    ACTA RADIOL 2017 10.1177/0284185116673122

    Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging

    Song1, KD; Rhim, H; Lee, MW; Kim, YS; Kang, TW

    Korean J Radiol. 2017 May-Jun;18(3):427-443. doi: 10.3348/kjr.2017.18.3.427. Epub 2017 Apr 3.

    Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal. Radiology

    1,Korean Society of Abdominal Radiology.

    Eur Radiol. 2017 Apr;27(4):1722-1732. doi: 10.1007/s00330-016-4522-0. Epub 2016 Aug 10.

    Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping

    Kim M11, Jang KM2,3, Kim JH4, Jeong WK4, Kim SH4, Kang TW4, Kim YK4, Cha DI4, Kim K5.

    Cardiovasc Intervent Radiol. 2017 Mar;40(3):401-409. doi: 10.1007/s00270-016-1525-9. Epub 2016 Dec 8.

    Radiofrequency Ablation of Hepatocellular Carcinoma with a "Nodule-in-Nodule" Appearance: Long-Term Follow-up and Clinical Implications

    Kang TW11, Rhim H2, Song KD1, Lee MW1, Cha DI1, Ha SY3, Ahn JH4.

    Br J Radiol. 2017 Mar;90(1071):20160361. doi: 10.1259/bjr.20160361. Epub 2017 Jan 31.

    Chronological changes of radiofrequency ablation zone in rabbit liver: an in vivo correlation between gross pathology and histopathology

    Song KD11, Lee MW1, Rhim H1, Kang TW1, Cha DI1, Yang J2.

    CLINICAL RADIOLOGY, FEB 2017, 72(2):141-149, DOI: 10.1016/j.crad.2016.09.008

    Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma

    Kim SS1, Kang TW, Song KD, Cho SK, Lee MW, Rhim H, Sinn DH, Jung SH

    Korean J Radiol. 2017 Jan-Feb;18(1):152-161. doi: 10.3348/kjr.2017.18.1.152. Epub 2017 Jan 5.

    Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance

    Kang TW11, Lee MW1, Song KD1, Kim M1, Kim SS1, Kim SH1, Ha SY2.

    Korean J Radiol. 2017 Jan-Feb;18(1):173-179. doi: 10.3348/kjr.2017.18.1.173. Epub 2017 Jan 5.

    New Radiofrequency Device to Reduce Bleeding after Core Needle Biopsy: Experimental Study in a Porcine Liver Model

    Lim S11, Rhim H2, Lee MW2, Song KD2, Kang TW2, Kim YS2, Lim HK2.

    Clin Radiol. 2016 Apr;71(4):402.e9-402.e15. doi: 10.1016/j.crad.2016.01.004. Epub 2016 Feb 10.

    Tumefactive gallbladder sludge: the MRI findings

    Seong M11, Kang TW2, Kim M1, Kim SS1, Jang KM1, Kim YK1, Kim SH1.

    Liver Int. 2016 Apr;36(4):580-7. doi: 10.1111/liv.12991. Epub 2015 Nov 18.

    Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma

    Lee S11, Rhim H1, Kim YS1, Kang TW1, Song KD1.

    Eur J Radiol. 2016 Mar;85(3):680-7. doi: 10.1016/j.ejrad.2015.12.029. Epub 2016 Jan 4.

    Pancreatic neuroendocrine tumour: Correlation of apparent diffusion coefficient or WHO classification with recurrence-free survival

    Kim M11, Kang TW2, Kim YK1, Kim SH1, Kwon W3, Ha SY4, Ji SA5.

    AJR Am J Roentgenol. 2016 Feb;206(2):291-300. doi: 10.2214/AJR.15.14974.

    Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings

    Choi SY11, Kim SH2, Kang TW2, Song KD2, Park HJ3, Choi YH4.

    AJR Am J Roentgenol. 2016 Nov;207(5):1122-1127. Epub 2016 Aug 30.

    Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma After Combined Transarterial Chemoembolization and Radiofrequency Ablation

    Song KD11, Lee MW1, Rhim H1, Kim YS1, Kang TW1, Shin SW1, Cho SK1.

    Radiology. 2016 Oct;281(1):119-28. doi: 10.1148/radiol.2016151781. Epub 2016 Apr 26.

    Mass-forming Intrahepatic Cholangiocarcinoma: Diffusion-weighted Imaging as a Preoperative Prognostic Marker

    Lee J11, Kim SH1, Kang TW1, Song KD1, Choi D1, Jang KT1.

    Eur Radiol. 2016 Oct;26(10):3437-46. doi: 10.1007/s00330-015-4190-5. Epub 2016 Jan 8.

    Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma

    Kang TW11, Rhim H2, Lee J1, Song KD1, Lee MW1, Kim YS1, Lim HK1, Jang KM1, Kim SH1, Gwak GY3, Jung SH4.

    Eur Radiol. 2016 Sep;26(9):3102-11. doi: 10.1007/s00330-015-4136-y. Epub 2015 Dec 3.

    Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis

    Park HJ11, Jang KM2, Kang TW3, Song KD3, Kim SH3, Kim YK3, Cha DI3, Kim J4, Goo J4.

    Liver Int. 2016 Aug;36(8):1187-95. doi: 10.1111/liv.13081. Epub 2016 Mar 15.

    Effect of parenchymal uptake of perfluorobutane microbubbles (Sonazoid((R))) on radiofrequency ablation of the liver: in vivo experimental study

    Min JH11, Kim YS1, Rhim H1, Lee MW1, Kang TW1, Song KD1, Lim HK1,2.

    Radiology. 2016 Jul;280(1):300-12. doi: 10.1148/radiol.2016151243. Epub 2016 Jan 29.

    Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study

    Kang TW11, Lim HK1, Lee MW1, Kim YS1, Rhim H1, Lee WJ1, Paik YH1, Kim MJ1, Ahn JH1.

    Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026.

    Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma

    Sohn W11,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.

    Br J Radiol. 2016 Jul;89(1063):20160054. doi: 10.1259/bjr.20160054. Epub 2016 May 10.

    The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses

    Choi SY11, Kim SH2, Jang KM2, Kang TW2, Song KD2, Moon JY3, Choi YH4, Lee BR5.

    J Vasc Interv Radiol. 2016 Jun;27(6):846-51. doi: 10.1016/j.jvir.2016.01.148. Epub 2016 Apr 11.

    Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey

    Kang TW11, Lee MW2, Choi D1, An C3, Kim MJ3, Joo I4, Lee SJ5, Lim S6, Park JG7, Seo JW8, Jung SH9.

    RADIOLOGY,SEP 2015,276(3):933-933

    Aggressive Intrasegmental Recurrence of Periportal Hepatocellular Carcinoma after Radiofrequency Ablation: Role of Ablative Technique and Heat-Sink Effect Response

    Kang TW1, Lim HK

    Invest Radiol. 2015 Feb;50(2):81-7. doi: 10.1097/RLI.0000000000000103.

    A Novel Electrode With Electromagnetic Tip Tracking in Ultrasonography-Guided Radiofrequency Ablation A Phantom, Ex Vivo, and In Vivo Experimental Study

    Kang TW11, Lee MW, Choi SH, Rhim H, Lim S, Song KD, Min JH, Choi SY, Lim HK, Yang J.

    Eur J Radiol. 2015 Nov;84(11):2089-96. doi: 10.1016/j.ejrad.2015.08.007. Epub 2015 Aug 20.

    Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication

    Kang TW11, Kim SH2, Lee J1, Kim AY1, Jang KM1, Choi D1, Kim MJ3.

    Korean J Radiol. 2015 Nov-Dec;16(6):1253-6. doi: 10.3348/kjr.2015.16.6.1253. Epub 2015 Oct 26.

    Pancreatic Candidiasis That Mimics a Malignant Pancreatic Cystic Tumor on Magnetic Resonance Imaging: A Case Report in an Immunocompetent Patient

    Seong M11, Kang TW1, Ha SY2.

    Eur J Radiol. 2015 Jan;84(1):33-40. doi: 10.1016/j.ejrad.2014.10.020. Epub 2014 Nov 8.

    Gastrointestinal stromal tumours: Correlation of modified NIH risk stratification with diffusion-weighted MR imaging as an imaging biomarker

    Kang TW11, Kim SH2, Jang KM1, Choi D1, Ha SY3, Kim KM3, Kang WK4, Kim MJ5.

    Radiology. 2015 Jul;276(1):274-85. doi: 10.1148/radiol.15141215. Epub 2015 Feb 25.

    Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance

    Kang TW11, Lim HK1, Lee MW1, Kim YS1, Rhim H1, Lee WJ1, Gwak GY1, Paik YH1, Lim HY1, Kim MJ1.

    Radiology. 2015 Jun;275(3):908-19. doi: 10.1148/radiol.15141483. Epub 2015 Feb 16.

    Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection-Propensity Score Analyses of Long-term Outcomes

    Kang TW11, Kim JM, Rhim H, Lee MW, Kim YS, Lim HK, Choi D, Song KD, Kwon CH, Joh JW, Paik SW, Paik YH, Ahn JH.

    Br J Radiol. 2015 Jun;88(1050):20140497. doi: 10.1259/bjr.20140497. Epub 2015 Apr 17.

    Hepatic radiofrequency ablation: in vivo and ex vivo comparisons of 15-gauge (G) and 17-G internally cooled electrodes

    Song KD11, Lee MW, Park HJ, Cha DI, Kang TW, Lee J, Moon JY, Rhim H.

    Clin Radiol. 2015 Apr;70(4):387-94. doi: 10.1016/j.crad.2014.12.003. Epub 2015 Jan 9.

    Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography

    Park HJ11, Lee MW2, Rhim H1, Cha DI1, Kang TW1, Lim S1, Song KD1, Lim HK1.

    Eur J Radiol. 2015 Apr;84(4):555-62. doi: 10.1016/j.ejrad.2014.12.023. Epub 2015 Jan 7.

    Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease

    Kim HS11, Kim SH2, Kang TW1, Song KD1, Choi D1, Park CK3.

    CLINICAL RADIOLOGY, MAY 2014, 69(5): 509-518, 10.1016/j.crad.2013.12.018

    Inflammatory myofibroblastic tumours of the liver: Gadoxetic acid-enhanced and diffusion-weighted MRI findings with F-18-FDG PET/CT and clinical significance of regression on follow-up

    Kang TW1, Kim SH, Jang KM, Choi D, Choi JY, Park CK

    Br J Radiol. 2014 Apr;87(1036):20130534. doi: 10.1259/bjr.20130534.

    Comparison of therapeutic efficacy and safety of radiofrequency ablation of hepatocellular carcinomas between internally cooled 15-G and 17-G single electrodes

    Park HJ1, Lee MW, Song KD, Cha DI, Rhim H, Kang TW, Lim S, Lim HK.

    World J Gastroenterol. 2014 Apr 14;20(14):4059-65. doi: 10.3748/wjg.v20.i14.4059.

    Single hepatocellular carcinoma <= 3 cm in left lateral segment: Liver resection or radiofrequency ablation

    Kim JM11, Kang TW1, Kwon CH1, Joh JW1, Ko JS1, Park JB1, Rhim H1, Lee JH1, Kim SJ1, Paik SW1.

    Radiology. 2014 Mar;270(3):888-99. doi: 10.1148/radiol.13130753. Epub 2013 Nov 22.

    Perivascular versus Nonperivascular Small HCC Treated with Percutaneous RF Ablation: Retrospective Comparison of Long-term Therapeutic Outcomes

    Kang TW11, Lim HK, Lee MW, Kim YS, Choi D, Rhim H.

    J Vasc Interv Radiol. 2014 Feb;25(2):307-14. doi: 10.1016/j.jvir.2013.10.025. Epub 2013 Dec 5.

    Mistargeting after Fusion Imaging-Guided Percutaneous Radiofrequency Ablation of Hepatocellular Carcinomas

    Lim S11, Lee MW2, Rhim H1, Cha DI1, Kang TW1, Min JH1, Song KD1, Choi SY1, Lim HK1.

    Clin Radiol. 2014 Dec;69(12):1249-58. doi: 10.1016/j.crad.2014.07.012. Epub 2014 Aug 20.

    radiofrequency ablation of hepatic tumours: Factors affecting technical failure of artificial ascites formation using an angiosheath

    Kang TW11, Lee MW2, Hye MJ1, Song KD1, Lim S1, Rhim H1, Lim HK1, Cha DI1.

    AJR Am J Roentgenol. 2014 Nov;203(5):992-1000. doi: 10.2214/AJR.13.11980.

    Value of Diffusion-Weighted MRI for Differentiating Malignant From Benign Intraductal Papillary Mucinous Neoplasms of the Pancreas

    Jang KM11, Kim SH, Min JH, Lee SJ, Kang TW, Lim S, Choi D.

    AJR Am J Roentgenol. 2014 Oct;203(4):803-12. doi: 10.2214/AJR.13.11914.

    Differentiation of Malignant From Benign Focal Splenic Lesions: Added Value of Diffusion-Weighted MRI

    Jang KM11, Kim SH, Hwang J, Lee SJ, Kang TW, Lee MW, Choi D.

    Korean J Radiol. 2014 Jan-Feb;15(1):95-107. doi: 10.3348/kjr.2014.15.1.95. Epub 2014 Jan 8.

    Terminology and Reporting Criteria for Radiofrequency Ablation of Tumors in the Scientific Literature: Systematic Review of Compliance with Reporting Standards

    Kang TW11, Rhim H1, Lee MW1, Kim YS1, Choi D1, Lim HK1.

    CLOSE

    Patients' Rights and Responsibilities

    Patients' Rights

    1. Right to receive medical care

    Patients have the right to receive proper care in a safe setting without discrimination nor should their right to care be violated regardless of their gender, age, religion, social status, nationality, language, race, or physical/mental/financial status. Medical teams shall not refuse to provide care without justifiable reason.

    2. Right to be informed and to make an autonomous decision

    Patients have the right to obtain full and complete information from their medical team, to ask questions, and to determine their agreement or refusal concerning: diagnosis, treatment (purpose, plans and methods), outcomes of care (including unanticipated outcomes), discharge plan, participation in medical research studies, organ transplantation/donation, etc. Within ethical boundaries, patients may discontinue or refuse treatment, request that the medical team explain and suggest alternative treatments, and reserve the right to make their own decisions.

    3. Right to confidentiality

    Patients' rights to confidentiality regarding their physical/health status and privacy will not be violated. Patients can expect that all medical records/reports and their personal privacy will be kept confidential unless the patient has given consent or disclosure is permitted by law. To ensure their privacy, patients may be informed that Individuals not directly involved in their care may not be present and that the number of guardians accompanying patients to consultation rooms may be limited.

    4. Right to request consultation and mediation

    In the event of a medical dispute, patients may request consultation and mediation from an internal or external agency (Korea Consumer Agency, Korea Medical Dispute Mediation and Arbitration Agency).

    5. Right to have values and beliefs respected

    Patients will not be discriminated against because of their culture, religious values, or beliefs, and their rights will not be violated.

    6. Right to receive care in a safe setting

    Patients have the right to receive hospital-provided care where the patient’s medical information is protected and patient safety can be assured. In addition, patients have the right to be protected from possible dangers that can occur in a hospital and to have stability of mind and body.

    Patients' Responsibilities

    1. Responsibility to trust and respect the medical team

    Patients must accurately inform the medical team of their health condition and must trust and respect the medical team's treatment plan. Patients may be responsible for consequences that result from not following instructions.

    2. Responsibility to not use dishonest methods for medical treatment

    Patients must reveal their identity before receiving any medical care and must not use false or dishonest methods, such as seeking medical care under disguised ownership.

    3. Responsibility to abide by all hospital regulations

    Patients are expected to treat all hospital staff and other patients with courtesy and respect; to abide by all hospital rules; and to earnestly fulfill their financial obligation to the hospital. Also, patients and their family members are expected to participate in all safety regulations.